(Q51609980)

8 April 2018

title

Double-blind Crossover Study of Acarbose in Type 1 Diabetic Patients (English)

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01676.X

5 December 2022

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01676.X

5 December 2022

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01676.X

5 December 2022

author name string

S. Marena

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1833121

5 December 2022

V. Tagliaferro

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1833121

5 December 2022

G. Cavallero

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1833121

5 December 2022

A. Pagani

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1833121

5 December 2022

G. Montegrosso

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1833121

5 December 2022

W. Bianchi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1833121

5 December 2022

P. Zaccarini

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1833121

5 December 2022

G. Pagano

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1833121

5 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1833121

5 December 2022

publication date

1 August 1991

1 reference

8 April 2018

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1464-5491.1991.tb01676.x

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01676.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-5491.1991.tb01676.x/fullpdf

5 December 2022

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01676.X

5 December 2022

1 reference

8 April 2018

volume

8

1 reference

8 April 2018

issue

7

1 reference

8 April 2018

page(s)

674-678

1 reference

8 April 2018

Treatment of poorly controlled non-insulin-dependent diabetic patients with Acarbose

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.1991.TB01676.X

Effect of acarbose on carbohydrate and lipid metabolism in NIDDM patients poorly controlled by sulfonylureas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.1991.TB01676.X

Inhibition of human intestinalα-glucosidehydrolases by a new complex oligosaccharide

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01676.X

Reduction of carbohydrate-induced hypertriglyceridemia in (fa,fa) "Zucker" rats by the alpha-glucosidase inhibitor acarbose (BAY g 5421)

5 December 2022

4

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01676.X

Scope and specificity of acarbose in slowing carbohydrate absorption in man

5 December 2022

5

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01676.X

The Effects of an Alpha-Glucoside Hydrolase Inhibitor on Glycemia and the Absorption of Sucrose in Man Determined Using a Tracer Method

5 December 2022

6

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01676.X

alpha-Glucosidase inhibition improves postprandial hyperglycemia and decreases insulin requirements in insulin-dependent diabetes mellitus

5 December 2022

11

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01676.X

Effects of prolonged (6 months) alpha-glucosidase inhibition on blood glucose control and insulin requirements in patients with insulin-dependent diabetes mellitus

5 December 2022

14

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01676.X

Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group

5 December 2022

19

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01676.X

Fate and effects of the alpha-glucosidase inhibitor acarbose in humans. An intestinal slow-marker perfusion study

5 December 2022

21

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01676.X

Metformin reduces insulin requirement in Type 1 (insulin-dependent) diabetes

5 December 2022

23

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01676.X

Effects of alpha-glucosidase inhibition and viscous fibre on diabetic control and postprandial gut hormone responses

5 December 2022

26

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01676.X

The role of circulating glucose and triglyceride concentrations and their interactions with other "risk factors" as determinants of arterial disease in nine diabetic population samples from the WHO multinational study.

5 December 2022

28

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01676.X

5 December 2022

Identifiers

1 reference

8 April 2018

1 reference

8 April 2018